P Constans, A Baron, R Parrot, C Coury. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAgedBilirubin/bloodDrug Resistance, MicrobialEthambutol/administration & dosageEthambutol/therapeutic useFemaleFollow-Up StudiesHumansIsoniazid/administration & dosageIsoniazid/therapeutic useJaundice/chemically inducedMaleMiddle AgedMycobacterium tuberculosis/isolation & purificationRecurrenceRifampin/administration & dosageRifampin/adverse effectsRifampin/therapeutic useSputum/microbiologyTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/microbiologyTuberculosis, Pulmonary/pathology
Substances: See more » EthambutolBilirubinIsoniazidRifampin
Year: 1972 PMID: 4624276 DOI: 10.1378/chest.61.6_supplement.539
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410